Bernard de Bruyne

Showing 1-20 of 26 articles

Coronary interventions

Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE Trial.

El Farissi M, Keulards D, van 't Veer M, Zelis JM, Berry C, de Bruyne B, Engstrøm T, Fröbert O, Piroth Z, Oldroyd K, Tonino P, Pijls N, Otterspoor L

September 10, 2019 | 10.4244/EIJ-D-19-00471

Coronary interventions

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial

Toth G, de Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, van Mieghem CAG, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

July 2, 2019 | 10.4244/EIJ-D-19-00463

Coronary interventions

Pellicano M, Di Gioia G, Ciccarelli G, Xaplanteris P, Delrue L, Toth G, Van Durme F, Heyse A, Wyffels E, Vanderheyden M, Bartunek J, de Bruyne B, Barbato E

May 14, 2019 | 10.4244/EIJ-D-18-01138

Coronary interventions

Qualitative resting coronary pressure wave form analysis to predict fractional flow reserve

Matsumura M, Maehara A, Johnson N, Fearon W, de Bruyne B, Oldroyd K, Pijls N, Jenkins P, Ali Z, Mintz G, Stone G, Jeremias A

February 7, 2019 | 10.4244/EIJ-D-17-01149

Stable CAD

Coronary lesion progression as assessed by fractional flow reserve (FFR) and angiography

Xaplanteris P, Ntalianis A, de Bruyne B, Strisciuglio T, Pellicano M, Ciccarelli G, Milkas A, Barbato E

October 19, 2018 | 10.4244/EIJ-D-17-00872

Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study

Svanerud J, Ahn J, Jeremias A, van ‘t Veer M, Gore A, Maehara A, Crowley A, Pijls N, de Bruyne B, Johnson N, Hennigan B, Watkins S, Berry C, Oldroyd K, Park S-J, Ali Z

September 20, 2018 | 10.4244/EIJ-D-18-00342

Coronary interventions

Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation

van’t Veer M, Adjedj J, Wijnbergen I, Toth G, Rutten M, Barbato E, Van Nunen L, Pijls N, de Bruyne B

August 20, 2016 | 10.4244/EIJV12I6A114

Interventions for valvular disease

Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve

Sawaya F, Kappetein AP, Wisser W, Nataf P, Thomas M, Schächinger V, de Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T

August 20, 2016

Coronary interventions

Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry

Iñiguez A, Brener S, Jimenez V, Maehara A, Mintz G, Xu K, Weisz G, Lansky A, de Bruyne B, Serruys P, Stone G

April 20, 2016 | 10.4244/EIJV11I13A285

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

Serruys P, Onuma Y, Garcia-Garcia H, Muramatsu T, van Geuns R, de Bruyne B, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert K, Rapoza R, Ormiston J

March 20, 2014 | 10.4244/EIJV9I11A217

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

Gogas B, Bourantas C, Garcia-Garcia H, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns R, de Bruyne B, Chevalier B, Thuesen L, Smits P, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston J, Serruys P

October 25, 2013 | 10.4244/EIJV9I6A115

Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function

Di Serafino L, Pyxaras S, Mangiacapra F, Dierickx K, Toth G, Bartunek J, de Bruyne B, van Mieghem CAG, Wijns W, Barbato E

March 22, 2013 | 10.4244/EIJV8I11A193

Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study

Ruiz-Garc J, Lerman A, Weisz G, Maehara A, Mintz G, Fahy M, Xu K, Lansky A, Cristea E, Farah T, Teles R, Bøtker H, Templin B, Zhang Z, de Bruyne B, Serruys P, Stone G

December 28, 2012 | 10.4244/EIJV8I8A142

A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial

Karjalainen P, Niemelä M, Airaksinen J, Rivero-Crespo F, Romppanen H, Sia J, Lalmand J, de Bruyne B, De Belder A, Carlier M, Nammas W, Ylitalo A, Hess O

July 27, 2012 | 10.4244/EIJV8I3A49

Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction

Muller O, Delrue L, Hamilos M, Vercauteren S, Ntalianis A, Trana C, Mangiacapra F, Dierickx K, de Bruyne B, Wijns W, Behfar A, Barbato E, Terzic A, Vanderheyden M, Bartunek J

August 30, 2011 | 10.4244/EIJV7I4A75

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

Brugaletta S, Garcia-Garcia H, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin E, van Geuns R, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston J, Serruys P

April 20, 2011

FFR in bifurcation stenting: what have we learned?

Koo B, de Bruyne B

January 11, 2011

Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis

Melikian N, Vercauteren S, Fearon W, Cuisset T, MacCarthy P, Davidavicius G, Aarnoudse W, Bartunek J, Vanderheyden M, Wyffels E, Wijns W, Heyndrickx G, Pijls N, de Bruyne B

April 12, 2010

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

van Domburg R, Daemen J, Morice M, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Van Es G-A, Wittebols K, Macours N, Stoll H, Serruys P

April 12, 2010

The recurrence of iatrogenic femoral artery pseudoaneurysm after occlusion by ultrasound guided percutaneous thrombin injection

Madaric J, Mistrik A, Vulev I, Liska B, Vozar M, Lederer P, Gocar M, Kozlovska T, Fridrich V, de Bruyne B, Bartunek J

September 30, 2009

Latest news

New issue

Discover the Special Edition on valvular heart disease prepared for PCR London Valves

(3D-TEE model - Optimal implantation)

November 15, 2019

Free access

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Free Access

New this week: Deep Learning, near-infrared spectroscopy and much more

November 12, 2019

Trials Book

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Free access

Guidelines, consensus & position papers

April 9, 2019

Insight

The SYNTAX score on its way out or … towards artificial intelligence

November 1, 2019

Free access

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Bernard de Bruyne

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke